实时血液动力学辅助的同时动脉和心心膜内替换
Siddhartha Mengi1, Dimitri Kalavrouziotis1, Pierre-Yves Turgeon1
1Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
JACC. Case reports
|August 1, 2025
概括
这项研究表明,同时进行内透导管大动脉置换 (ViV-TAVR) 和中置换 (ViV-TMVR) 是可行的,对于生物假体失效的高风险患者来说是安全的. 在SavvyWire技术提高程序的精度和安全性.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 生物假体门技术的使用
背景情况:
- 生物假体失效是一个重大的临床挑战,特别是在高风险的手术患者.
- 过导管内 (ViV) 程序,包括ViV过导管大动脉置换 (ViV-TAVR) 和ViV过导管中置换 (ViV-TMVR),提供了一个不那么侵入性的替代方案.
- 同时穿皮ViV-TAVR和ViV-TMVR是一种新兴的策略,支持数据有限.
研究的目的:
- 报告一个同时进行膜转移ViV-TAVR和横管ViV-TMVR的病例.
- 评估这种联合穿皮方法的可行性,安全性和效率.
- 突出新技术在促进复杂程序中的作用.
主要方法:
- 一名高风险的70岁患者在主动脉和 mitra 生物假体中患有严重的假体内吐,接受了该程序.
- 患者接受了输血的ViV-TAVR和交叉面的ViV-TMVR.
- 该SavvyWire被用于实时血液动力学监测和左心室节奏.
主要成果:
- 同时的ViV-TAVR和ViV-TMVR程序在技术上是成功的.
- 患者在手术后立即经历了血液动力学改善.
- 没有观察到任何程序性并发症.
结论:
- 同时进行膜输血的ViV-TAVR和ViV-TMVR是生物假体门衰竭高风险患者的可行,安全和高效的选择.
- 在提高程序精度和安全方面,SavvyWire证明了它的实用性.
- 需要进一步的研究,以在更大的队列中验证这些发现.
相关概念视频
01:26Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
01:25Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
01:25Aortic Regurgitation III: Medical Management
43
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
01:22Mitral Valve Prolapse II: Assessment and Management
40
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
40
01:27Mitral Stenosis IV: Nursing Management
47
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
47
01:28Mitral Regurgitation IV: Nursing Management
83
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
83